Go behind the scenes with Scrip, as expert analysts examine the machinations of Roche’s acquisition of Spark Therapeutics, Inc. Find out in this informative article how Roche secured the deal in the face of strong competition from three other rival companies.
Author: Kevin Grogan
Published: 08 March 2019
Number of pages:2
Examine the behind-the-scenes action regarding Roche’s acquisition of Spark Therapeutics Inc. in this insightful article from Scrip. Analysts dissect a Securities and Exchange (SEC) commission filing by Spark to paint a picture of the skillful negotiating tactics employed by Spark CEO Jeff Marrazzo. See how his plan resulted in successfully driving up Spark’s per share price by more than 60% over its first offer, and how Roche ultimately secured the acquisition. Get the details on this $4.8b deal here.
Datamonitor Healthcare is part of Pharma intelligence
Datamonitor Healthcare is a trading division of Datamonitor Limited, a company registered in England and Wales with company number 2306113 whose registered office is 5 Howick Place, London, SW1P 1WG. VAT GB365462636. Datamonitor Limited is part of Informa PLC.
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726